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Introduction 
Stem cells have long been regarded as undifferentiated and capable of 
indefinite proliferation, self-renewal, and provision of a large number of 
differentiated cells. Certain cells in postnatal tissues retain their ability to 
divide and self-renew, and have been categorized based on their differentiation 
capacity: hematopoietic, bone, epithelial muscle-, neural-, and hepatic stem 
cells, and so on. Adult stem cells are able to give rise to the cells of their tissue 
of residence. Mesenchymal stem cells (MSC) were first found in the rodent 
bone marrow (BM), as non-hematopoietic, multipotent progenitors. MSC are 
adherent to plastic in culture, capable of colony formation and differentiation 
into osteoblasts, adipocytes and chondrocytes in vitro. Consequently, stromal 
cells with colony forming and multipotent differentiation capacity were 
isolated from a perivascular position in many postnatal organs. The main role 
of MSC is to maintain stem cell niches. A single colony forming unit 
fibroblast (CFU-F), isolated from the bone marrow, when transplanted 
ectopically (subcutaneously), can differentiate into all the cell types of a 
miniature bone-organ (ossicle), is able to recreate the hematopoietic 
microenvironment (HME) and capable of self-renewal, during serial 
transplantation. MSC also have been shown to secrete a wide range of pro-
angiogenic factors, and have been proposed to have a key role in the support 
of blood vessel formation and regeneration, given their perivascular position 
and the still growing body of evidence. Also, cultured MSC were shown to 
modulate the tissue response to injury by numerous studies. Due to the 
promising results shown in preclinical models, the relatively easy isolation and 
culture expansion, the low risk of immune-rejection and the lack of ethical 
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concerns, MSC have become popular candidates for regenerative cell therapy, 
and have made one of the fastest transitions from the bench to the clinic. 
However, MSC therapy has yielded modest, even neutral results in terms of 
efficacy in the cardiovascular field.  
Accordingly, various strategies have been investigated in order to 
improve the survival and retention of stem cells after injection, for example, 
hypoxic, hyperoxic and pharmacological preconditioning of MSC.  Hypoxia 
exerts strong effects on MSC, affecting their proliferation, differentiation and 
migration. However, studies have yielded controversial results, which might 
be caused by the variation in the conditions that have been tested, including 
time- span (ranging from minutes to days) and level of hypoxia: from 0.1 to 
10% O2. It has been demonstrated previously that hypoxic preconditioning 
enhances the therapeutic potential of MSC in applications such as the 
treatment of cardiac ischemia, critical limb ischemia, traumatic brain injury, 
and in liver regeneration. The further understanding of MSC biology and 
response to hypoxia, especially in terms of the secretion of angiogenic factors 
could be remarkably useful for enhancing the efficacy of MSC-based therapy 
(Bianco et al 2013). It has been long established that lipids (fatty acids and 
their derivatives and substances related biosynthetically or functionally to 
these compounds) are not only essential building blocks of biological 
membranes and responsible for energy storage in the cell, but also have 
important regulatory and signaling functions in almost all cellular processes, 
such as hypoxic signaling (Hannun and Obeid, 2008). To date, little is known 
about the overall lipidomics of human MSC, or changes in lipid composition 
in response to stimuli such as hypoxia. 
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Aims of the study 
The aims of the first set of experiments were (1) to examine the 
effects of various levels of hypoxia on MSC, and (2) to study the effects of 
hypoxic exposure prior to their administration to a hypoxic site, which we 
refer to as hypoxic pre‐conditioning (HP). We sought (3) to determine the 
optimal hypoxia levels and incubation times to promote survival of MSC in an 
environment of low oxygen and nutrients. In addition, (4) we sought to 
evaluate the underlying mechanism(s) that promote the survival of MSC and 
hypothesized, that hypoxic pre‐conditioning promotes metabolic adaptations 
in MSCs that allow increased survival under conditions of limited nutrients 
and oxygen. To further study the effect of hypoxia on mesenchymal stem 
cells, our aims were (5) to determine the lipid composition of human bone 
marrow derived MSC, (6) to identify changes induced by exposure to hypoxia 
and (7) to evaluate whether these changes have a role in the angiogenic 
potential of MSC. 
Methods 
Isolation and culture of MSC 
Bone marrow aspirates from human donors were purchased from 
Lonza (Walkersville, USA) or Stem Express (Placerville, USA) and 
mesenchymal stem cells were isolated as described previously. For studies 
with hypoxia, cell cultures were performed in incubators at 37°C with 5% 
CO2, humidified atmosphere and dedicated oxygen level (20 (atmospheric), 
10, 5 or 1% O2), as established by replacement with nitrogen injections. 
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Cell proliferation and cell cycle analysis 
During proliferation assays, cells were lifted at the given time points 
with trypsin treatment and counted using Trypan blue exclusion dye and a 
hemocytometer. To determine the status in cell cycle, cells were lifted, 
permeabilized with ethanol, incubated with propidium iodide, and evaluated 
by flow cytometry. 
In vitro cell survival and apoptosis detection 
To evaluate survival of MSC in hypoxia and serum deprivation, we 
first incubated MSC in standard culture medium and 1% O2, for varying 
amounts of time (0 (control group), 16, 48 or 96 hours). Then, culture media 
was changed to MEMα alone (without FBS) and all plates were transferred to 
1% O2 for up to 12 days with no additional media changes. Every three days, 
cells were counted. To quantify the percentage of dead cells, MSC were 
cultured on glass cover slips and incubated for 48 hours in standard culture 
medium in 20% O2 (control) or 1% O2 (HP). Then, medium was changed to 
serum free medium and plates were transferred to 1% O2 for 9 days with no 
additional media changes. Cover slips were then incubated in 4 μM Ethidium- 
homodimer III, images were acquired using a fluorescence microscope, and 
analyzed for automated counting. For apoptosis detection, cells were lifted 
using trypsin, stained with phycoerythrin-Annexin V-Apoptosis Detection Kit 
I and measured by flow cytometry. 
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In vivo retention study 
First, we generated luciferase-expressing MSC using the lentiviral 
vector with the general form pCCLc-MNDU3-Luciferase-PGK-eGFP-WPRE. 
Cells were isolated from 3 donors, ad cultured in either 1% or 20% O2 for 48 
hours. For cell administration, immune compromised NOD/SCID-IL2Rγ-/- 
(NSG) mice were injected in the medial hamstring muscles with 2 x 10
5 
luciferase-expressing MSC in 20 uL of HyStem C (14 animals per group), and 
cell retention was followed for 28 days using in vivo imaging system (IVIS). 
Glucose and lactate measurements 
Supernatants were collected every 3 days from MSC cultured under 
identical conditions to the in vitro survival assay, and the glucose and lactate 
measurements were performed using a Glucose or Lactate Colorimetric assay 
kit. 
Ultrahigh pressure liquid chromatography- quadrupole time-of-flight tandem 
mass spectrometry (UHPLC- QTOF-MS/MS) 
MSC were cultured in either 1% or 20% O2 for 48 hours, lifted with 
trypsin, and processed for lipidomics analysis as described by Fiehn and Kind 
(2007).  Lipidomics data were acquired using UHPLC – QTOF MS/MS. 
Chromatographic separation was followed by electrospray ionization (ESI) in 
both positive and negative mode; and QTOF-MS/MS. Data were analyzed in a 
four-stage process. Annotated lipids are abbreviated as: [Lipid class] [total 
carbon number in the chains]:[total number of double bonds in the chains]. 
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Measurement of DG levels by enzyme-linked immunosorbent assay (ELISA) 
MSC were cultured in 20% or 1% O2, with or without PI-PLC enzyme 
blocker D609 (50 μM)). MSC in normoxia were also tested in the presence of 
the hypoxia-mimicking agent Cobalt Chloride (100 μM). After 48 hours, cells 
were lifted by trypsin treatment, and lipids were extracted as described 
previously by Bligh and Dyer (1959). To measure DG levels, we used the 
Human Diacylglycerol ELISA Kit. 
Detection of angiogenic factors 
MSC were cultured as described for DG measurements, and VEGF, 
interleukin-8 and angiopoietin-2 protein levels were detected in the 
supernatant media by the respective ELISA kits. To measure mRNA levels of 
VEGF, interleukin-8 and angiopoietin-2, total RNA was extracted, reverse 
transcription, then real time PCR were performed using TaqMan 
primers/probes. 
Wound/scratch assay 
Conditioned media of MSC were prepared as described for DG 
measurements, and stored at -80 
o
C. VeraVecs endothelial cells were seeded in 
plates containing plastic inserts, which leave a homogeneous 500 μm gap in 
between confluent monolayers of cells. The next day, inserts were removed 
and media was changed to the conditioned media from MSC. Pictures were 
taken immediately, and 10 hours after adding conditioned media and  analyzed 
using TScratch software. Wound closure was determined as [open image area 
after 10h / initial open image area] x 100. 
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Statistical analysis and presentation of data 
All experiments were performed at least three times with MSC 
derived from different donors. The specific number of biological replicates for 
each experiment is indicated in the respective figure legend as n. In 
accordance, results are shown as average with the standard error of the mean 
(SEM) as error bars. When only two conditions were tested, a Student’s t-test 
was used, where significant differences are denoted as: * p < 0.05 and ** p < 
0.005. In contrast, in experiments where four conditions were tested, analysis 
of variance (ANOVA) or a Student’s t-test with Bonferroni correction were 
applied, with significant differences from control indicated as * p < 0.0125. In 
lipidomics experiments, values are given as mean +/- SEM. A paired Student 
t-test was used to determine statistically significant differences established as 
p < 0.05 (see in the respective results sections). 
Results 
Proliferation and differentiation is inhibited by hypoxia in a dose-dependent 
manner 
We tested the effect of varying levels of hypoxia (1%, 5%, 10% and 
20% O2) on proliferation and differentiation of human BM-MSC, and found 
that hypoxia caused a decrease in the proliferation and diffentiation of MSC, 
proportional to the degree of hypoxia, as assessed by proliferation assays, cell 
cycle analysis and adipogenic and osteogenic differentiation assays. Culture 
under 1% O2 had the strongest effect on MSC, while 10% O2 seemed to only 
have a mild effect on the proliferation and differentiation of MSC. 
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Hypoxic pre-conditioning increases survival of MSC in vitro 
To simulate an environment poor in nutrients and oxygen, cells were 
transferred to 1% O2 in serum-free media for 12 days. We observed that for all 
experimental conditions, no living cells were present after 12 days under 
serum deprivation and hypoxia. However, MSC that received hypoxic 
preconditioning for 48 or 96 hours showed an approximately 2-fold increase in 
survival at 6 days under serum deprivation and hypoxia as compared to 
control MSC, while 16 hours of hypoxic preconditioning had no effect on 
survival as compared to controls. To further support these results, MSC were 
stained with EthD‐III or Annexin V, and we found that after 9 days in hypoxia 
and serum deprivation, 48 hour- HP‐MSC showed over a 2‐fold reduction in 
dead cells as compared to controls, and there were significantly less apoptotic 
cells in the HP-MSC group, than in the control MSC group.  
Hypoxic preconditioning enhances retention of MSC in vivo 
We injected luciferase- expressing MSC intramuscularly into immune 
deficient mice and followed their retention over time. First, we established a 
correlation between IVIS- detected luminescence and cell number, generating 
a standard curve by injecting increasing numbers of MSC into the medial 
hamstring muscles of immune deficient NSG mice and measured 
luminescence immediately thereafter. We then addressed cellular retention 
with and without hypoxic preconditioning using the standard curve to 
determine the number of retained cells after injection over time. We found that 
MSC cultured under 20% O2 prior to injection, are retained for one week after 
transplantation, but start to decrease rapidly thereafter and are undetectable at 
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28 days after cell injection. In contrast, we could detect MSC with 48-hour 
hypoxic preconditioning after 28 days. Cell retention of HP- MSC was also 
significantly better at day 14 and day 21 after administration as compared to 
control MSC. 
Hypoxic preconditioned-MSC have more glucose available during serum-
deprivation in vitro 
We first cultured cells under 1% O2 for 0, 16, 48, and 96 hours, and 
found that glucose levels of supernatant media are significantly higher in MSC 
cultured in hypoxia for 96 hours, and that lactate levels were increased in 
MSC cultured in hypoxia as compared to controls. In the next set of 
experiments, after 3 days in serum deprivation and hypoxia, glucose levels 
were over 2-fold higher, and lactate levels were significantly lower in 
supernatant media of 48 and 96 hours HP- MSC, as compared to controls 
(without HP). 
Lipid composition of MSC 
MSC from 5 healthy human donors were cultured for 48 hours in 20% 
or 1% O2, and processed for total lipid analysis by mass spectrometry. Using a 
HPLC- ESI- QTOF MS/MS method, a total of 1,965 different molecular ions 
were detected. 390 ions (21.2%) could be identified as putative lipid species 
using the most comprehensive lipid database to date, LipidBLAST. From 
these, phosphatidylcholine species accounted for 76.5% of all identified lipids, 
followed by sphyngomyelin (11%), phosphatidylethanolamine (2%) and 
triglyceride (2%) species. Altogether, PC, SM, PE and TG accounted for over 
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90% of all annotated lipids detected in MSC. The lipid detected most 
abundantly was PC (18:1/16:0) accounting for 13.1% of all annotated lipids. 
Hypoxia induces changes in the lipid composition of MSC and increases the 
level of diacyglycerols 
In order to identify changes in lipid composition of MSC induced by 
hypoxia, we performed two types of analysis. First, we grouped the detected 
species by lipid class and performed a Student’s t-test to identify significant 
differences by class between normoxia and hypoxia. We found that TG, DG 
and fatty acids were significantly increased in MSC exposed to hypoxia by 
4.8, 1.8 and 1.3-fold respectively, as compared to MSC in normoxia. 41 lipid 
species (10.5%) were significantly increased in hypoxic MSC as compared to 
controls. We found that each of the 7 detected DG species was significantly 
increased in MSC under hypoxia. We confirmed these results measuring DG 
levels with ELISA method, in hypoxia and normoxia, and in the presence of 
the hypoxia mimicking agent CoCl2. To evaluate the possible effects of 
increased DG levels in MSC in hypoxia, we used D609, an inhibitor of PC-
PLC and SMS. We found that addition of D609 (50 μM) reduced DG levels in 
MSC cultured under hypoxia. Interestingly, D609 did not reduce DG levels in 
MSC under normoxia. 
Reduction of diacylglycerol levels with D609 affects secretion of angiogenic 
proteins in MSC 
After incubation of MSC for 48 hours in normoxia or hypoxia, with or 
without D609, supernatant conditioned media were collected and the amount 
of secreted VEGF, CXCL8/IL-8 and Ang-2 were measured by ELISA. We 
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observed a significant increase in VEGF secretion in MSC exposed to 
hypoxia, while addition of D609 (i.e. the reduction of DG levels) caused a 
decrease in VEGF levels in MSC in both normoxia and hypoxia. In contrast, 
secreted IL-8 levels were reduced by hypoxia, while addition of the enzyme 
inhibitor D609 increased IL-8 secretion in MSC in both normoxia and 
hypoxia. Secreted levels of Ang-2 by MSC were overall very low. However, 
we detected a slight decrease in Ang-2 secretion in MSC exposed to hypoxia, 
as compared to controls, while addition of D609 reduced Ang-2 secretion even 
further in MSC in both normoxia and hypoxia.  Overall, these trends are very 
similar at mRNA levels, measured after incubation for 12 hours in hypoxia. 
However, only mRNA levels of VEGF and Ang-2 showed a similar trend to 
the respective secreted protein levels. Our results show that VEGF and Ang-2 
are both regulated transcriptionally by hypoxia, however all other differences 
in mRNA levels in between conditions were not significant. 
Reduction of DG levels in MSC limits their potential to induce migration of 
endothelial cells in vitro 
To further investigate whether the increase of DG in MSC under 
hypoxia could exert a functional effect, we prepared conditioned media from 
MSC cultured under normoxia or hypoxia and in the presence or absence of 
D609. We then tested whether these conditioned media affected the migration 
of human endothelial cells in vitro, using a wound healing assay. We found 
that endothelial cells migrated less in the preconditioned media from D609 
treated hypoxic MSC than non-treated hypoxic MSC. However, D609 
treatment did not cause a difference in the migration-inducing capacity of 
MSC in normoxia. 
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Conclusions 
Despite the paramount of data about paracrine factor secretion and 
beneficial effects on tissue repair in preclinical models, most clinical trials 
have failed to show robust recovery in cardiovascular disease patients, with 
the regenerative capacity of MSC somehow ‘lost in translation’. Indeed, as 
discussed above, various factors are possibly responsible for this phenomenon, 
which highlights the utmost importance of conducting well-designed 
experiments focused on the nature, basic biology and differentiation potential 
of MSC. On the other hand, efforts must be aimed at improving the survival 
and engraftment rates of the injected cells. In my opinion, the combined 
application of stem cell therapy and various biomaterials could lead to a more 
successful path in the future. 
It has been previously demonstrated that hypoxic preconditioning 
enhances the therapeutic potential of MSC in applications such as treatment of 
cardiac ischemia (Hu X, et al. 2008, He A et al 2009), critical limb ischemia 
(Rosova et al 2008, Huang et al 2014, Leroux et al 2010), traumatic brain 
injury (Chang et al 2013), and in liver regeneration (Yu J et al 2013). One of 
the key factors in the hypoxic preconditioning- induced enhancement of tissue 
repair seems to be the increased retention of MSC in tissues (Hu et al. 2008, 
Huang et al 2014 Leroux et al 2010), but the underlying mechanisms remain 
elusive. We tested the effects of varying levels of hypoxia on proliferation and 
differentiation of human MSC, and observed that hypoxia caused a decrease in 
the proliferation of MSC, and inhibited their osteogenic and adipogenic 
differentiation proportionally to the degree of hypoxia. Our conclusion is that 
the proliferation and differentiation of MSC are inhibited by hypoxia in a 
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dose-dependent manner, and that the lowest level of oxygen used, 1% O2 
(equivalent to 10 mmHg O2 in the culture media) exerted the strongest 
inhibitory effect on MSC, especially during osteogenic differentiation. 
We also addressed the effect of HP on the survival of cells upon new 
exposure to hypoxia, and found 1% oxygen is an optimal level for 
preconditioning, and established an optimal duration of preconditioning: in 
our experiments, 16 hours of HP did not have a profound effect on survival, 
while 48 and 96 hours of HP transitorily promoted cell survival to a similar 
degree in an in vitro environment with limited oxygen and nutrients. 
Importantly, 48 hours of HP significantly increased cell retention after in vivo 
transplantation. Overall, our results strongly encourage, at both the clinical 
and research level, pre-incubation of MSC in hypoxia prior to transplantation 
to enhance their retention. We also investigated the underlying mechanism(s) 
that promote the survival of hypoxic preconditioned MSC and found that 
glucose levels are significantly higher in MSC cultured in hypoxia for 96 
hours, suggesting that under this condition MSC use up less glucose as 
compared to normoxic controls. After 3 days in serum deprivation and 
hypoxia, glucose levels were over 2-fold higher in supernatant media of 48 
and 96 hours hypoxic preconditioned MSC, as compared to controls (without 
hypoxic preconditioning). We propose that, under limited glucose availability, 
hypoxic preconditioned MSC survive for a longer period of time due to a 
lower rate of glucose consumption, thereby allowing more glucose availability 
over a longer period of time. 
Further understanding MSC biology and response to hypoxia, 
especially in terms of the secretion of angiogenic factors could be remarkably 
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useful for enhancing the efficacy of MSC-based therapy (Bianco et al 2013). It 
has long been established that lipids are crucial first and second messenger 
molecules (van Meer et al., 2008) and it has also been shown that lipids are 
involved in hypoxic signaling (Ueda et al 1998, Vlassaks et al 2013). 
Analyzing the lipid composition of MSC using HPLC-QTOF-MS/MS and the 
LipidBLAST library, we found a strong up-regulation of many lipids in MSC 
exposed for 48 hours to hypoxia and especially noteworthy was the increase of 
all detected DG species. To study the effects of increased DG levels in 
hypoxia, we used D609, to reduce overall DG levels (Adibhatla et al 2012), 
and evaluated the effect on the angiogenic factors secreted by MSC. In line 
with previous publications, we observed a significant increase in VEGF 
secretion in MSC exposed to hypoxia, while D609 caused a decrease in VEGF 
levels in MSC in both normoxia and hypoxia. In contrast, secreted IL-8 levels 
were reduced by hypoxia, while addition of D609 increased IL-8 secretion in 
MSC in both normoxia and hypoxia. Secreted levels of Ang-2 by MSC were 
overall very low. Altogether, our results suggest that DGs are involved in the 
secretion of VEGF, IL-8 and Ang-2 in MSC in both normoxic and hypoxic 
conditions. We also tested whether conditioned media from MSC cultured 
under either normoxia or hypoxia and in the presence or absence of D609 
affect the migration of human endothelial cells in vitro, using a wound healing 
assay. Our results indicate that conditioned media from MSC cultured under 
hypoxia promote endothelial cell migration to a similar extent than MSC 
under normoxia. However, under hypoxia, addition of D609 reduced the 
migration of endothelial cells, suggesting that the increase of DG in MSC 
under hypoxia is an important mechanism to alter the angiogenic secretome of 
MSC. This suggests that the specific signals of MSC promoting migration of 
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endothelial cells are distinct under normoxia and hypoxia, where under 
hypoxia signals are more dependent on DG levels. The results of our 
experiments measuring DG levels in response to hypoxia and D609 also 
strengthen this argument, since D609 treatment for 48 hours inhibited DG 
levels in MSC only under hypoxia. Although these are in vitro results, 
cautioning their interpretation, it is interesting to note, that blocking the 
increase in DG levels in hypoxia seems to have functional consequences in the 
migration-inducing capacity of MSC. 
The changes in lipid composition presented here offer new insight into 
the changes that MSC undergo under hypoxia, which are important rather 
from the perspective of the bench, but could impact the therapeutic application 
at the bedside. 
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